Publications
Chiu VK, Bivona T, Hach A, Sajous JB, Silletti J, Wiener H, Johnson RL, Cox AD, Philips MR. Ras signalling on the endoplasmic reticulum and the Golgi. Nature cell biology. 2002. PMID: 11988737
Bergsland EK, Venook AP. Shedding old paradigms: developing viruses to treat cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002. PMID: 11980991
Kohlwes RJ, Chou CL. A curriculum in medical economics for residents. Academic medicine : journal of the Association of American Medical Colleges. 2002. PMID: 12010725
Ko AH, Tempero MA. Current and future strategies for combined-modality therapy in pancreatic cancer. Current oncology reports. 2002. PMID: 11937010
Rini BI, Small EJ. Prostate cancer update. Current opinion in oncology. 2002. PMID: 11981273
Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M. Hemorrhage and VEGF expression in a case of primary CNS lymphoma. Journal of neuro-oncology. 2002. PMID: 12160141
Moasser MM, Rosen N. The use of molecular markers in farnesyltransferase inhibitor (FTI) therapy of breast cancer. Breast cancer research and treatment. 2002. PMID: 12088116
Park JW. Liposome-based drug delivery in breast cancer treatment. Breast cancer research : BCR. 2002. PMID: 12052251
Huang F, Stremlau M. Training to think globally. Nature. 2002. PMID: 11948324
Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clinical cancer research : an official journal of the American Association for Cancer Research. 2002. PMID: 11948130
Robibaro B, Stedman TT, Coppens I, Ngô HM, Pypaert M, Bivona T, Nam HW, Joiner KA. Toxoplasma gondii Rab5 enhances cholesterol acquisition from host cells. Cellular microbiology. 2002. PMID: 11906451
Hosing C, Munsell M, Yazji S, Andersson B, Couriel D, de Lima M, Donato M, Gajewski J, Giralt S, Körbling M, Martin T, Ueno NT, Champlin RE, Khouri IF. Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2002. PMID: 11996478
Tutt AN, van Oostrom CT, Ross GM, van Steeg H, Ashworth A. Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation. EMBO reports. 2002. PMID: 11850397
Basso AD, Solit DB, Munster PN, Rosen N. Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2. Oncogene. 2002. PMID: 11850835
Harmon EB, Ko AH, Kim SK. Hedgehog signaling in gastrointestinal development and disease. Volume 2 of Issue 1 Current molecular medicine. 2002. PMID: 11898849
Oh WK, Small EJ. PC-SPES and prostate cancer. The Urologic clinics of North America. 2002. PMID: 12109356
Linker CA, Damon LE, Ries CA, Navarro WA, Case D, Wolf JL. Autologous stem cell transplantation for advanced acute myeloid leukemia. Bone marrow transplantation. 2002. PMID: 11896426
Komanduri KV. Thymic function and allogeneic T-cell responses in stem-cell transplantation. Cytotherapy. 2002. PMID: 12396833
Augustine SC, Norenberg JP, Colcher DM, Vose JM, Gobar LS, Dukat VJ, Hohenstein MA, Rutar FJ, Jacobson DA, Tempero MA. Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practice. Journal of the American Pharmaceutical Association (Washington, D.C. : 1996). 2002. PMID: 11833524
Gordan JD, Vonderheide RH. Universal tumor antigens as targets for immunotherapy. Cytotherapy. 2002. PMID: 12396831